中国当代医药
中國噹代醫藥
중국당대의약
China Modern Medicine
2015年
28期
130-132
,共3页
儿童支原体肺炎%阿奇霉素%布地奈德%临床效果
兒童支原體肺炎%阿奇黴素%佈地奈德%臨床效果
인동지원체폐염%아기매소%포지내덕%림상효과
Children Mycoplasma pneumonia%Azithromycin%Budesonide%Clinical effect
目的：探讨儿童肺炎支原体感染进行布地奈德与阿奇霉素联合治疗的临床效果。方法选取我院2013年4月~2014年3月的94例肺炎支原体感染患儿，按照随机数字表法分为研究组和对照组，每组47例。两组均行常规治疗，对照组在常规治疗基础上行阿奇霉素治疗，研究组在对照组基础上行布地奈德雾化吸入治疗。治疗3周后，对比两组临床效果以及不良反应状况。结果研究组的临床总有效率为87.2%，显著高于对照组66.0%，差异有统计学意义(P<0.05)；研究组的X线平片、啰音、咳嗽、喘息等恢复情况显著优于对照组(P<0.05)；研究组用药后不良反应发生率为14.9%，对照组为8.5%，两组差异无统计学意义(P>0.05)。结论儿童支原体肺炎应用布地奈德联合阿奇霉素治疗，可缩短其治疗时间，且安全有效，可促进患儿的病情康复，值得临床推广。
目的：探討兒童肺炎支原體感染進行佈地奈德與阿奇黴素聯閤治療的臨床效果。方法選取我院2013年4月~2014年3月的94例肺炎支原體感染患兒，按照隨機數字錶法分為研究組和對照組，每組47例。兩組均行常規治療，對照組在常規治療基礎上行阿奇黴素治療，研究組在對照組基礎上行佈地奈德霧化吸入治療。治療3週後，對比兩組臨床效果以及不良反應狀況。結果研究組的臨床總有效率為87.2%，顯著高于對照組66.0%，差異有統計學意義(P<0.05)；研究組的X線平片、啰音、咳嗽、喘息等恢複情況顯著優于對照組(P<0.05)；研究組用藥後不良反應髮生率為14.9%，對照組為8.5%，兩組差異無統計學意義(P>0.05)。結論兒童支原體肺炎應用佈地奈德聯閤阿奇黴素治療，可縮短其治療時間，且安全有效，可促進患兒的病情康複，值得臨床推廣。
목적：탐토인동폐염지원체감염진행포지내덕여아기매소연합치료적림상효과。방법선취아원2013년4월~2014년3월적94례폐염지원체감염환인，안조수궤수자표법분위연구조화대조조，매조47례。량조균행상규치료，대조조재상규치료기출상행아기매소치료，연구조재대조조기출상행포지내덕무화흡입치료。치료3주후，대비량조림상효과이급불량반응상황。결과연구조적림상총유효솔위87.2%，현저고우대조조66.0%，차이유통계학의의(P<0.05)；연구조적X선평편、라음、해수、천식등회복정황현저우우대조조(P<0.05)；연구조용약후불량반응발생솔위14.9%，대조조위8.5%，량조차이무통계학의의(P>0.05)。결론인동지원체폐염응용포지내덕연합아기매소치료，가축단기치료시간，차안전유효，가촉진환인적병정강복，치득림상추엄。
Objective To clinical effect of Budesonide combined with Azithromycin for children with Mycoplasma pneu-monia infection. Methods 94 children with Mycoplasma pneumonia infection treated in our hospital from April 2013 to March 2014 were selected.They were randomly divided into research group and control group according to the random number table method,47 cases in each group.Two groups were given conventional treatment,the control group was adopted azithromycin on the basis of conventional treatment,research group was adopted azithromycin on the basis of control group. After 3weeks of treatment,the clinical effect,remission of clinical symptoms and adverse reactions in two groups were compared. Results The effective rate of research group was 87.2%,which was significantly higher than 66.0%of control group(P<0.05).The recovery of breathing, coughing,rale,X-ray plain of research group was significantly better than those of control group (P<0.05).The adverse event rate of research group and control group was 14.9% and 8.5%,the difference was not statistically significant between two groups (P>0.05). Conclusion For children with My-coplasma pneumonia infection,budesonide combined with azithromycin has an obvious clinical effect,can shorten the treatment time and promote the patient’s disease rehabilitation,and is safe and effective.which is worthy of clinical pro-motion.
